Doxorubicin cardiomyopathy: underlying cause of interferon-induced cardiac dysfunction?

被引：0
作者：
Geffen, D. B. [1 ]
Liel-Cohen, N.
机构：
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Oncol, IL-84105 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Univ Hosp, Div Cardiol, IL-84105 Beer Sheva, Israel
来源：
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2007年 / 9卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：690 / 690
页数：1
相关论文
共 4 条
[1]  
Benjamini O, 2007, ISRAEL MED ASSOC J, V9, P486
[2]   Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults [J].
Hequet, O ;
Le, QH ;
Moullet, I ;
Pauli, E ;
Salles, G ;
Espinouse, D ;
Dumontet, C ;
Thieblemont, C ;
Arnaud, P ;
Antal, D ;
Bouafia, F ;
Coiffier, B .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1864-1871
[3]   Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials [J].
Swain, SM ;
Whaley, FS ;
Ewer, MS .
CANCER, 2003, 97 (11) :2869-2879
[4]   RISK-FACTORS FOR DOXORUBICIN-INDUCED CONGESTIVE HEART-FAILURE [J].
VONHOFF, DD ;
LAYARD, MW ;
BASA, P ;
DAVIS, HL ;
VONHOFF, AL ;
ROZENCWEIG, M ;
MUGGIA, FM .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (05) :710-717
1